Ocular Therapeutix Inc OCUL
NASDAQ · United States · Health Technology
$7.29-0.38 (-4.95%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | -0.35 | -0.40 | +11.5% | $13.48M | +2.1% | +5.1%$8.17→$8.59 |
| Q1 2026 | 2026-05-05 | -0.40 | -0.31 | -29.0% | — | — | -0.6%$9.77→$9.71 |
| Q4 2025 | 2026-02-05 | -0.29 | -0.34 | +14.7% | — | — | +7.1%$8.55→$9.16 |
| Q3 2025 | 2025-11-04 | -0.38 | -0.35 | -8.6% | — | — | -5.3%$11.41→$10.81 |
| Q2 2025 | 2025-08-05 | -0.39 | -0.35 | -11.4% | — | — | — |
| Q1 2025 | 2025-05-05 | -0.37 | -0.28 | -32.1% | — | — | — |
| Q4 2024 | 2025-03-03 | -0.29 | -0.22 | -31.8% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.22 | -0.21 | -4.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.